{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T20:35:55Z","timestamp":1781296555845,"version":"3.54.1"},"reference-count":58,"publisher":"SAGE Publications","issue":"4_suppl","license":[{"start":{"date-parts":[[2024,7,24]],"date-time":"2024-07-24T00:00:00Z","timestamp":1721779200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"funder":[{"name":"Personal Care Products Council"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Int J Toxicol"],"published-print":{"date-parts":[[2024,10]]},"abstract":"<jats:p>The Expert Panel for Cosmetic Ingredient Safety (Panel) assessed the safety of three methylxanthines, Caffeine, Theobromine, and Theophylline, as used in cosmetics. All of these ingredients are reported to function as skin-conditioning agents in cosmetic products. The Panel reviewed the data relevant to the safety of these ingredients and concluded that Caffeine, Theobromine, and Theophylline are safe in cosmetics in the present practices of use and concentration described in this safety assessment.<\/jats:p>","DOI":"10.1177\/10915818241260282","type":"journal-article","created":{"date-parts":[[2024,7,25]],"date-time":"2024-07-25T00:58:53Z","timestamp":1721869133000},"page":"42-77","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":6,"title":["Safety Assessment of Methylxanthines as Used in Cosmetics"],"prefix":"10.1177","volume":"43","author":[{"given":"Priya A.","family":"Cherian","sequence":"first","affiliation":[{"name":"Cosmetic Ingredient Review Senior Scientific Analyst\/Writer"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wilma F.","family":"Bergfeld","sequence":"additional","affiliation":[{"name":"Expert Panel for Cosmetic Ingredient Safety Member"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donald V.","family":"Belsito","sequence":"additional","affiliation":[{"name":"Expert Panel for Cosmetic Ingredient Safety Member"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald A.","family":"Hill","sequence":"additional","affiliation":[{"name":"Expert Panel for Cosmetic Ingredient Safety Former Member"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Curtis D.","family":"Klaassen","sequence":"additional","affiliation":[{"name":"Expert Panel for Cosmetic Ingredient Safety Member"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel C.","family":"Liebler","sequence":"additional","affiliation":[{"name":"Expert Panel for Cosmetic Ingredient Safety Former Member"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr.","given":"James G.","family":"Marks","sequence":"additional","affiliation":[{"name":"Expert Panel for Cosmetic Ingredient Safety Former Member"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald C.","family":"Shank","sequence":"additional","affiliation":[{"name":"Expert Panel for Cosmetic Ingredient Safety Former Member"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas J.","family":"Slaga","sequence":"additional","affiliation":[{"name":"Expert Panel for Cosmetic Ingredient Safety Member"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul W.","family":"Snyder","sequence":"additional","affiliation":[{"name":"Expert Panel for Cosmetic Ingredient Safety Member"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monice","family":"Fiume","sequence":"additional","affiliation":[{"name":"Cosmetic Ingredient Review Senior Director"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bart","family":"Heldreth","sequence":"additional","affiliation":[{"name":"Cosmetic Ingredient Review Executive Director"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2024,7,24]]},"reference":[{"key":"bibr1-10915818241260282","unstructured":"Nikitakis J, Lange B, eds. Web-Based Ingredient Dictionary (wINCI). https:\/\/webdictionary.personalcarecouncil.org\/jsp\/IngredientSearchPage.jsp. Washington, D.C. Last Updated 2017. Date Accessed 9-6-2017."},{"key":"bibr2-10915818241260282","unstructured":"European Chemicals Agency (ECHA). REACH registration dossier: Caffeine (CAS No. 58-08-2). https:\/\/echa.europa.eu\/registration-dossier\/-\/registered-dossier\/10085. Last Updated 2017. Date Accessed 9-6-2017."},{"key":"bibr3-10915818241260282","unstructured":"European Chemicals Agency (ECHA). REACH registration dossier: Theobromine (CAS No. 83-67-0). https:\/\/echa.europa.eu\/registration-dossier\/-\/registered-dossier\/17899. Last Updated 2017. Date Accessed 9-6-2017."},{"key":"bibr4-10915818241260282","unstructured":"European Chemicals Agency (ECHA). REACH registration dossier: Theophylline (CAS No. 58-55-9). https:\/\/echa.europa.eu\/registration-dossier\/-\/registered-dossier\/11172\/7\/6\/2. Last Updated 2017. Date Accessed 4-11-0018."},{"key":"bibr5-10915818241260282","unstructured":"Organisation for Economic Cooperation and Development (OECD). SIDS Initial Assessment Report for SIAM 14: Caffeine (CAS: 58-08-2). 2002. https:\/\/webnet.oecd.org\/HPV\/UI\/handler.axd?id=cedcd78d-4ddd-4a9c-b0f0-3b53f8fd5495. Date Accessed 9-6-2017."},{"key":"bibr6-10915818241260282","unstructured":"Organisation for Economic Cooperation and Development (OECD). SIDS initial assessment report for SIAM 13: Theophylline (CAS: 58-55-9). 2001. https:\/\/www.inchem.org\/documents\/sids\/sids\/theophil.pdf. Date Accessed 4-12-2018."},{"key":"bibr7-10915818241260282","first-page":"557","author":"Wansi JD","year":"2013","journal-title":"Pharmacology and Chemistry"},{"key":"bibr8-10915818241260282","doi-asserted-by":"publisher","DOI":"10.2741\/1975"},{"key":"bibr9-10915818241260282","doi-asserted-by":"publisher","DOI":"10.1124\/mi.7.5.1"},{"key":"bibr10-10915818241260282","unstructured":"International Agency for Research on Cancer (IARC) World Health Organization (WHO). 1991. IARC Monographs on the Evaluation of Carcinogeic Risks to Humans.\n                      Coffee, Tea, Mate, Methylxanthines, and Methylglyoxal\n                      . Volume 51. Lyon, France https:\/\/monographs.iarc.fr\/ENG\/Monographs\/vol51\/mono51.pdf. Date Accessed 9-6-2017."},{"key":"bibr11-10915818241260282","unstructured":"PubChem Compound Database. Compound summary for CID 2519: Caffeine. https:\/\/pubchem.ncbi.nlm.nih.gov\/compound\/2519#section=Color. Last Updated 2018. Date Accessed 4-10-0018."},{"key":"bibr12-10915818241260282","unstructured":"PubChem Compound Database. Compound summary for CID 5429: Theobromine. https:\/\/pubchem.ncbi.nlm.nih.gov\/compound\/5429. Last Updated 2018. Date Accessed 4-11-2018."},{"key":"bibr13-10915818241260282","unstructured":"PubChem Compound Database. Compound summary for CID 2153: Theophylline. https:\/\/pubchem.ncbi.nlm.nih.gov\/compound\/2153#section=Top. Last Updated 2018. Date Accessed 4-11-2018."},{"key":"bibr14-10915818241260282","volume-title":"Food Chemicals Codex","author":"United States Pharmacopeial Convention and Council of Experts","year":"2016","edition":"10"},{"key":"bibr15-10915818241260282","unstructured":"Council of Experts. U.S. Pharmacopeia National Formulary. 2009."},{"key":"bibr16-10915818241260282","unstructured":"The Department of Health. British Pharmacopoeia 2008. 2008."},{"key":"bibr17-10915818241260282","volume-title":"Voluntary Cosmetic Registration Program - Frequency of Use of Cosmetic Ingredients","author":"U.S. Food and Drug Administration (FDA) Center for Food Safety &amp; Applied Nutrition (CFSAN)","year":"2018"},{"key":"bibr18-10915818241260282","unstructured":"Personal Care Products Council. 2017. Concentration of use by FDA product category: Xanthine Alkaloids."},{"issue":"11","key":"bibr19-10915818241260282","first-page":"24","volume":"14","author":"Johnsen MA","year":"2004","journal-title":"Spray Technol Marketing"},{"key":"bibr20-10915818241260282","doi-asserted-by":"crossref","unstructured":"Rothe H. Special aspects of cosmetic spray evalulation. 2011.","DOI":"10.1016\/j.toxlet.2011.05.1038"},{"key":"bibr21-10915818241260282","doi-asserted-by":"publisher","DOI":"10.1016\/j.toxlet.2011.05.1038"},{"key":"bibr22-10915818241260282","unstructured":"Bremmer HJ, Prud\u2019homme de Lodder LCH, Engelen JGM. Cosmetics Fact Sheet: To Assess the Risks for the Consumer; Updated Version for ConsExpo 4. Bilthoven, Netherlands: Netherlands National Institute for Public Health and the Environment; 2006:1-77. https:\/\/www.rivm.nl\/bibliotheek\/rapporten\/320104001.pdf. Date Accessed 8-24-2011. Report No. RIVM 320104001\/2006."},{"key":"bibr23-10915818241260282","unstructured":"CIR Science and Support Committee of the Personal Care Products Council (CIR SSC). 2015. (Nov 3rd) Cosmetic Powder Exposure. Unpublished data submitted by the Personal Care Products Council."},{"key":"bibr24-10915818241260282","doi-asserted-by":"publisher","DOI":"10.1111\/j.1467-2494.1979.tb00212.x"},{"key":"bibr25-10915818241260282","doi-asserted-by":"publisher","DOI":"10.1016\/0015-6264(79)90208-6"},{"key":"bibr26-10915818241260282","unstructured":"European Commission. CosIng database; following Cosmetic Regulation No. 1223\/2009. https:\/\/ec.europa.eu\/growth\/tools-databases\/cosing\/. Last Updated 2016. Date Accessed 8-29-2017."},{"key":"bibr27-10915818241260282","unstructured":"Zeiger E. 1999. Caffeine and Its Modulating Effects (CAS No. 58-08-2). Research Triangle Park, North Carolina: Integrated Laboratory Systems https:\/\/ntp.niehs.nih.gov\/ntp\/htdocs\/chem_background\/exsumpdf\/caffeine_508.pdf. Date Accessed 4-18-2018."},{"key":"bibr28-10915818241260282","doi-asserted-by":"publisher","DOI":"10.1016\/j.fct.2013.10.042"},{"key":"bibr29-10915818241260282","doi-asserted-by":"publisher","DOI":"10.1159\/000313514"},{"key":"bibr30-10915818241260282","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2015.05.050"},{"key":"bibr31-10915818241260282","doi-asserted-by":"publisher","DOI":"10.1159\/000211027"},{"key":"bibr32-10915818241260282","doi-asserted-by":"publisher","DOI":"10.1007\/s00420-005-0056-5"},{"key":"bibr33-10915818241260282","doi-asserted-by":"publisher","DOI":"10.1111\/1523-1747.ep12499784"},{"key":"bibr34-10915818241260282","doi-asserted-by":"publisher","DOI":"10.1097\/FPC.0b013e3283505d5e"},{"key":"bibr35-10915818241260282","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2125.1999.00890.x"},{"key":"bibr36-10915818241260282","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.331.7517.633"},{"issue":"1","key":"bibr37-10915818241260282","first-page":"31","volume":"20","author":"Sarkar MA","year":"1992","journal-title":"Drug Metabol Dispos"},{"key":"bibr38-10915818241260282","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.2007.03065.x"},{"key":"bibr39-10915818241260282","doi-asserted-by":"publisher","DOI":"10.1016\/0278-6915(84)90365-X"},{"key":"bibr40-10915818241260282","doi-asserted-by":"publisher","DOI":"10.1016\/0021-9975(89)90089-3"},{"key":"bibr41-10915818241260282","unstructured":"U.S. National Toxicology Program (NTP). NTP Technical Report on the Toxicology and Carcinogenesis Studies of Theophylline (CAS No. 58-55-9) in F344\/N rats and B6C3F\n                      1\n                      mice (feed and gavage studies). 1988. https:\/\/ntp.niehs.nih.gov\/ntp\/htdocs\/lt_rpts\/tr473.pdf. Date Accessed 9-6-2017. Report No. TR 473."},{"key":"bibr42-10915818241260282","doi-asserted-by":"publisher","DOI":"10.1016\/S0041-008X(73)80003-1"},{"key":"bibr43-10915818241260282","doi-asserted-by":"publisher","DOI":"10.1016\/0027-5107(79)90159-3"},{"issue":"2","key":"bibr44-10915818241260282","first-page":"97","volume":"12","author":"Thayer PS","year":"2003","journal-title":"Mechanisms of Mutagenesis"},{"key":"bibr45-10915818241260282","doi-asserted-by":"publisher","DOI":"10.1111\/j.1745-4565.1978.tb00276.x"},{"key":"bibr46-10915818241260282","doi-asserted-by":"publisher","DOI":"10.1016\/0165-1218(86)90089-3"},{"issue":"3","key":"bibr47-10915818241260282","first-page":"457","volume":"33","author":"Slamenova D","year":"1986","journal-title":"Neoplasma"},{"key":"bibr48-10915818241260282","doi-asserted-by":"publisher","DOI":"10.1016\/0090-3019(83)90089-7"},{"key":"bibr49-10915818241260282","first-page":"687","volume":"2","author":"Friedman L","year":"1979","journal-title":"J Environ Pathol Toxicol"},{"key":"bibr50-10915818241260282","first-page":"2078","volume":"48","author":"Welsch C","year":"1988","journal-title":"Cancer Res"},{"key":"bibr51-10915818241260282","doi-asserted-by":"crossref","unstructured":"Personal Care Products Council. 2018. Caffeine.","DOI":"10.1016\/j.fos.2018.09.016"},{"key":"bibr52-10915818241260282","unstructured":"Anonymous. 2013. English synopsis: human repeated insult patch test with challenge body care product containing 6% Caffeine."},{"key":"bibr53-10915818241260282","unstructured":"Tice R, Brevard B. Caffeine and its modulating effects [58-08-2]. Research Triangle Park, North Carolina: integrated laboratory systems. 1999. Date Accessed 5-17-2018."},{"key":"bibr54-10915818241260282","unstructured":"NIH U.S.National Library of Medicine. 3,7 -Dimethylxanthine. Last Updated 2018. Date Accessed 7-9-2018."},{"key":"bibr55-10915818241260282","doi-asserted-by":"publisher","DOI":"10.1093\/toxsci\/17.4.696"},{"key":"bibr56-10915818241260282","doi-asserted-by":"publisher","DOI":"10.1002\/em.2860080802"},{"key":"bibr57-10915818241260282","unstructured":"U.S.National Toxicology Program. Testing status of caffeine 10036-G. https:\/\/ntp.niehs.nih.gov\/testing\/status\/agents\/ts-10036-g.html. Last Updated 2018. Date Accessed 5-17-2018."},{"key":"bibr58-10915818241260282","doi-asserted-by":"publisher","DOI":"10.1016\/0165-7992(82)90054-9"}],"container-title":["International Journal of Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/10915818241260282","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/10915818241260282","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/10915818241260282","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T10:24:49Z","timestamp":1777458289000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/10915818241260282"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,24]]},"references-count":58,"journal-issue":{"issue":"4_suppl","published-print":{"date-parts":[[2024,10]]}},"alternative-id":["10.1177\/10915818241260282"],"URL":"https:\/\/doi.org\/10.1177\/10915818241260282","relation":{},"ISSN":["1091-5818","1092-874X"],"issn-type":[{"value":"1091-5818","type":"print"},{"value":"1092-874X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,24]]}}}